title: Genetic information in the diagnosis and treatment of hypertension.
abstract: Advancement in cardiovascular science should be measured by a number of new diagnostic and therapeutic options applied in clinical practice as a result of translational research. Hypertension genetics is a good example of such a successful transfer of knowledge from bench to bedside. There are genetic methods currently used as diagnostic tools in patients presenting with secondary forms of hypertension, including primary hyperaldosteronism, Cushing's syndrome, pheochromocytoma, and chronic kidney disease. Directed treatment that corrects pathophysiologic abnormalities is available for several monogenic forms of hypertension as a result of uncovering their underlying genetic mechanisms. Progress in hypertension pharmacogenetics and pharmacogenomics brings closer a perspective of personalized antihypertensive treatment and gene transfer strategies, which, although still considered as innovative approaches, may soon become options to treat, control, and, possibly, cure hypertension.
authors.forename: Maciej
authors.initials: M
authors.lastname: Tomaszewski
authors.forename: Lukas
authors.initials: L
authors.lastname: Zimmerli
authors.forename: Fadi J
authors.initials: FJ
authors.lastname: Charchar
authors.forename: Anna F
authors.initials: AF
authors.lastname: Dominiczak
mesh_terms: D000308:Adrenocortical Hyperfunction / Q000175:diagnosis / Q000235:genetics; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects / Q000235:genetics; D005820:Genetic Testing; D023281:Genomics; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D009377:Multiple Endocrine Neoplasia / Q000175:diagnosis / Q000235:genetics; D010597:Pharmacogenetics; D010673:Pheochromocytoma / Q000175:diagnosis / Q000235:genetics; D016891:Polycystic Kidney, Autosomal Dominant / Q000175:diagnosis / Q000235:genetics
chemical_list: D000959:Antihypertensive Agents